Michael Barbella, Managing Editor05.22.24
The countdown is on.
Less than four months is left before Bio-Rad Executive Vice President and Chief Operating Officer Dr. Andrew Last retires (slated for early September). The company has already begun searching for his successor.
“Andy’s extensive operations experience, technical acumen, and leadership abilities have been invaluable to Bio-Rad over the past five years,” Bio-Rad President/CEO Norman Schwartz said. “We have made significant progress on our transformational objectives, including cost structure, core processes, and supply chain improvements, while effectively navigating various macroeconomic challenges.”
Dr. Last joined Bio-Rad Laboratories Inc. in April 2019 with more than 30 years of experience in global operations management in life sciences. Dr. Last will remain part of Bio-Rad’s executive leadership team to ensure a smooth transition while the company conducts a search for his successor.
“When I reflect on my tenure at Bio-Rad, I am most proud of the team we have built and the operations and management systems we have put in place," Last stated. "I am confident that these accomplishments have positioned Bio-Rad well for the next phase of its continued journey of transformation and growth.”
Bio-Rad Laboratories Inc. develops, manufactures, and markets products for the life science research and clinical diagnostics markets. Based in Hercules, Calif., Bio-Rad operates a global network of research, development, manufacturing, and sales operations with more than 8,000 employees and $2.7 billion in revenues in 2023. Its customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies.
Less than four months is left before Bio-Rad Executive Vice President and Chief Operating Officer Dr. Andrew Last retires (slated for early September). The company has already begun searching for his successor.
“Andy’s extensive operations experience, technical acumen, and leadership abilities have been invaluable to Bio-Rad over the past five years,” Bio-Rad President/CEO Norman Schwartz said. “We have made significant progress on our transformational objectives, including cost structure, core processes, and supply chain improvements, while effectively navigating various macroeconomic challenges.”
Dr. Last joined Bio-Rad Laboratories Inc. in April 2019 with more than 30 years of experience in global operations management in life sciences. Dr. Last will remain part of Bio-Rad’s executive leadership team to ensure a smooth transition while the company conducts a search for his successor.
“When I reflect on my tenure at Bio-Rad, I am most proud of the team we have built and the operations and management systems we have put in place," Last stated. "I am confident that these accomplishments have positioned Bio-Rad well for the next phase of its continued journey of transformation and growth.”
Bio-Rad Laboratories Inc. develops, manufactures, and markets products for the life science research and clinical diagnostics markets. Based in Hercules, Calif., Bio-Rad operates a global network of research, development, manufacturing, and sales operations with more than 8,000 employees and $2.7 billion in revenues in 2023. Its customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies.